Skip to content

Clinical trials

Completed Thromboembolism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thromboembolism Status: Completed Clear all

181 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20026
20038
20048
20055
200613
20079
20088
20098
20106
20117
20127
20137
20148
20159
201611
20176
20184
20193
202015
20213
20227
20234
20244
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed181

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer13
Boehringer Ingelheim10
GlaxoSmithKline9
Astellas Pharma Inc4
Daiichi Sankyo Co., Ltd.4
Beijing Chao Yang Hospital3
Brigham and Women's Hospital3
Inari Medical3
Karolinska Institutet3
University of Utah3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thromboembolism181
Thrombosis32
Venous Thromboembolism28
Venous Thrombosis25
Pulmonary Embolism22
Atrial Fibrillation20
Hemorrhage18
Stroke15
COVID-1911
Cardiovascular Diseases11

Trials

Showing 26 to 50 of 181. Each trial links to its page on Pharma Observatory.

81 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.